nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—ABCB1—Dactinomycin—muscle cancer	0.0829	0.176	CbGbCtD
Boceprevir—CYP3A5—Vincristine—muscle cancer	0.0785	0.166	CbGbCtD
Boceprevir—CYP3A5—Etoposide—muscle cancer	0.0719	0.152	CbGbCtD
Boceprevir—ABCB1—Vincristine—muscle cancer	0.0511	0.108	CbGbCtD
Boceprevir—ABCB1—Etoposide—muscle cancer	0.0468	0.0992	CbGbCtD
Boceprevir—ABCB1—Doxorubicin—muscle cancer	0.0319	0.0677	CbGbCtD
Boceprevir—ABCB1—Methotrexate—muscle cancer	0.0309	0.0655	CbGbCtD
Boceprevir—CYP3A4—Vincristine—muscle cancer	0.0306	0.0649	CbGbCtD
Boceprevir—CYP3A4—Etoposide—muscle cancer	0.028	0.0594	CbGbCtD
Boceprevir—CTSK—hindlimb—muscle cancer	0.0254	0.114	CbGeAlD
Boceprevir—CTSK—appendage—muscle cancer	0.0218	0.0974	CbGeAlD
Boceprevir—CYP3A4—Doxorubicin—muscle cancer	0.0191	0.0405	CbGbCtD
Boceprevir—CTSL—embryo—muscle cancer	0.00962	0.0429	CbGeAlD
Boceprevir—CTSV—renal system—muscle cancer	0.00892	0.0398	CbGeAlD
Boceprevir—CMA1—smooth muscle tissue—muscle cancer	0.00884	0.0395	CbGeAlD
Boceprevir—CTSL—smooth muscle tissue—muscle cancer	0.00756	0.0338	CbGeAlD
Boceprevir—CTSL—renal system—muscle cancer	0.00728	0.0325	CbGeAlD
Boceprevir—CTSL—cardiac atrium—muscle cancer	0.00652	0.0291	CbGeAlD
Boceprevir—CTSV—vagina—muscle cancer	0.00646	0.0288	CbGeAlD
Boceprevir—CMA1—bone marrow—muscle cancer	0.00644	0.0287	CbGeAlD
Boceprevir—CTSS—embryo—muscle cancer	0.00635	0.0284	CbGeAlD
Boceprevir—CTSV—head—muscle cancer	0.00597	0.0266	CbGeAlD
Boceprevir—CTSV—testis—muscle cancer	0.00576	0.0257	CbGeAlD
Boceprevir—CTSK—smooth muscle tissue—muscle cancer	0.0057	0.0254	CbGeAlD
Boceprevir—CTSL—tendon—muscle cancer	0.00568	0.0254	CbGeAlD
Boceprevir—CTSL—bone marrow—muscle cancer	0.00551	0.0246	CbGeAlD
Boceprevir—CTSK—renal system—muscle cancer	0.00549	0.0245	CbGeAlD
Boceprevir—CTSL—vagina—muscle cancer	0.00527	0.0235	CbGeAlD
Boceprevir—CTSS—smooth muscle tissue—muscle cancer	0.00499	0.0223	CbGeAlD
Boceprevir—CTSK—cardiac atrium—muscle cancer	0.00491	0.0219	CbGeAlD
Boceprevir—CTSL—head—muscle cancer	0.00487	0.0217	CbGeAlD
Boceprevir—CTSS—renal system—muscle cancer	0.00481	0.0215	CbGeAlD
Boceprevir—CTSL—testis—muscle cancer	0.00471	0.021	CbGeAlD
Boceprevir—CTSK—tendon—muscle cancer	0.00428	0.0191	CbGeAlD
Boceprevir—CTSK—bone marrow—muscle cancer	0.00415	0.0185	CbGeAlD
Boceprevir—CTSK—vagina—muscle cancer	0.00397	0.0177	CbGeAlD
Boceprevir—CTSS—tendon—muscle cancer	0.00375	0.0167	CbGeAlD
Boceprevir—CTSK—head—muscle cancer	0.00367	0.0164	CbGeAlD
Boceprevir—CTSS—bone marrow—muscle cancer	0.00364	0.0162	CbGeAlD
Boceprevir—CTSK—testis—muscle cancer	0.00355	0.0158	CbGeAlD
Boceprevir—CTSS—vagina—muscle cancer	0.00348	0.0155	CbGeAlD
Boceprevir—CTSS—head—muscle cancer	0.00322	0.0144	CbGeAlD
Boceprevir—CTSS—testis—muscle cancer	0.00311	0.0139	CbGeAlD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—WT1—muscle cancer	0.00245	0.0819	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—PTCH1—muscle cancer	0.00229	0.0765	CbGpPWpGaD
Boceprevir—CYP3A5—renal system—muscle cancer	0.0016	0.00713	CbGeAlD
Boceprevir—CTSV—Endochondral Ossification—IGF2—muscle cancer	0.00158	0.0528	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—TIMM10—muscle cancer	0.00134	0.0449	CbGpPWpGaD
Boceprevir—CYP3A4—renal system—muscle cancer	0.0012	0.00535	CbGeAlD
Boceprevir—CYP3A5—vagina—muscle cancer	0.00116	0.00516	CbGeAlD
Boceprevir—ABCB1—embryo—muscle cancer	0.00112	0.005	CbGeAlD
Boceprevir—CTSV—Extracellular matrix organization—DMD—muscle cancer	0.00107	0.0359	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—DMD—muscle cancer	0.00107	0.0359	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—DMD—muscle cancer	0.000998	0.0334	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—FOXO4—muscle cancer	0.000972	0.0325	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—DMD—muscle cancer	0.00089	0.0298	CbGpPWpGaD
Boceprevir—ABCB1—renal system—muscle cancer	0.000848	0.00379	CbGeAlD
Boceprevir—CTSS—Extracellular matrix organization—DMD—muscle cancer	0.000733	0.0245	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—FOXO1—muscle cancer	0.000718	0.024	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—VEGFA—muscle cancer	0.000662	0.0221	CbGpPWpGaD
Boceprevir—ABCB1—bone marrow—muscle cancer	0.000641	0.00286	CbGeAlD
Boceprevir—ABCB1—vagina—muscle cancer	0.000614	0.00274	CbGeAlD
Boceprevir—ABCB1—head—muscle cancer	0.000567	0.00253	CbGeAlD
Boceprevir—ABCB1—testis—muscle cancer	0.000548	0.00245	CbGeAlD
Boceprevir—CMA1—Signaling by SCF-KIT—KIT—muscle cancer	0.000547	0.0183	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD34—muscle cancer	0.000478	0.016	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD34—muscle cancer	0.000478	0.016	CbGpPWpGaD
Boceprevir—Gastrointestinal disorder—Vincristine—muscle cancer	0.000469	0.00171	CcSEcCtD
Boceprevir—Fatigue—Vincristine—muscle cancer	0.000469	0.00171	CcSEcCtD
Boceprevir—Hypertension—Etoposide—muscle cancer	0.000466	0.0017	CcSEcCtD
Boceprevir—Pain—Vincristine—muscle cancer	0.000465	0.00169	CcSEcCtD
Boceprevir—Constipation—Vincristine—muscle cancer	0.000465	0.00169	CcSEcCtD
Boceprevir—Pain in extremity—Doxorubicin—muscle cancer	0.000465	0.00169	CcSEcCtD
Boceprevir—Chest pain—Etoposide—muscle cancer	0.000459	0.00167	CcSEcCtD
Boceprevir—Eosinophilia—Methotrexate—muscle cancer	0.000459	0.00167	CcSEcCtD
Boceprevir—Migraine—Doxorubicin—muscle cancer	0.000457	0.00167	CcSEcCtD
Boceprevir—Affect lability—Doxorubicin—muscle cancer	0.000457	0.00167	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000456	0.00166	CcSEcCtD
Boceprevir—Pancreatitis—Methotrexate—muscle cancer	0.000455	0.00166	CcSEcCtD
Boceprevir—Discomfort—Etoposide—muscle cancer	0.000454	0.00165	CcSEcCtD
Boceprevir—Hypersensitivity—Dactinomycin—muscle cancer	0.000448	0.00163	CcSEcCtD
Boceprevir—Abdominal discomfort—Methotrexate—muscle cancer	0.000445	0.00162	CcSEcCtD
Boceprevir—Gastrointestinal pain—Vincristine—muscle cancer	0.000445	0.00162	CcSEcCtD
Boceprevir—Confusional state—Etoposide—muscle cancer	0.000444	0.00162	CcSEcCtD
Boceprevir—Pancytopenia—Methotrexate—muscle cancer	0.00044	0.00161	CcSEcCtD
Boceprevir—Mood swings—Doxorubicin—muscle cancer	0.00044	0.0016	CcSEcCtD
Boceprevir—Infection—Etoposide—muscle cancer	0.000437	0.00159	CcSEcCtD
Boceprevir—Asthenia—Dactinomycin—muscle cancer	0.000437	0.00159	CcSEcCtD
Boceprevir—Dysuria—Methotrexate—muscle cancer	0.000434	0.00158	CcSEcCtD
Boceprevir—Neutropenia—Methotrexate—muscle cancer	0.000434	0.00158	CcSEcCtD
Boceprevir—Dehydration—Doxorubicin—muscle cancer	0.000432	0.00158	CcSEcCtD
Boceprevir—Thrombocytopenia—Etoposide—muscle cancer	0.000431	0.00157	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—MDM2—muscle cancer	0.000431	0.0144	CbGpPWpGaD
Boceprevir—Tachycardia—Etoposide—muscle cancer	0.00043	0.00157	CcSEcCtD
Boceprevir—Body temperature increased—Vincristine—muscle cancer	0.00043	0.00157	CcSEcCtD
Boceprevir—Abdominal pain—Vincristine—muscle cancer	0.00043	0.00157	CcSEcCtD
Boceprevir—Skin disorder—Etoposide—muscle cancer	0.000428	0.00156	CcSEcCtD
Boceprevir—Erectile dysfunction—Methotrexate—muscle cancer	0.000427	0.00156	CcSEcCtD
Boceprevir—Dry skin—Doxorubicin—muscle cancer	0.000426	0.00155	CcSEcCtD
Boceprevir—Hyperhidrosis—Etoposide—muscle cancer	0.000426	0.00155	CcSEcCtD
Boceprevir—Abdominal pain upper—Doxorubicin—muscle cancer	0.000424	0.00155	CcSEcCtD
Boceprevir—Photosensitivity reaction—Methotrexate—muscle cancer	0.000423	0.00154	CcSEcCtD
Boceprevir—Hypokalaemia—Doxorubicin—muscle cancer	0.000423	0.00154	CcSEcCtD
Boceprevir—Breast disorder—Doxorubicin—muscle cancer	0.00042	0.00153	CcSEcCtD
Boceprevir—Diarrhoea—Dactinomycin—muscle cancer	0.000416	0.00152	CcSEcCtD
Boceprevir—Pneumonia—Methotrexate—muscle cancer	0.000416	0.00152	CcSEcCtD
Boceprevir—Nasopharyngitis—Doxorubicin—muscle cancer	0.000416	0.00151	CcSEcCtD
Boceprevir—Infestation NOS—Methotrexate—muscle cancer	0.000414	0.00151	CcSEcCtD
Boceprevir—Infestation—Methotrexate—muscle cancer	0.000414	0.00151	CcSEcCtD
Boceprevir—Depression—Methotrexate—muscle cancer	0.000412	0.0015	CcSEcCtD
Boceprevir—Hypotension—Etoposide—muscle cancer	0.000411	0.0015	CcSEcCtD
Boceprevir—Gastritis—Doxorubicin—muscle cancer	0.000411	0.0015	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00041	0.00149	CcSEcCtD
Boceprevir—Muscular weakness—Doxorubicin—muscle cancer	0.00041	0.00149	CcSEcCtD
Boceprevir—Abdominal distension—Doxorubicin—muscle cancer	0.000404	0.00147	CcSEcCtD
Boceprevir—Stomatitis—Methotrexate—muscle cancer	0.000403	0.00147	CcSEcCtD
Boceprevir—Conjunctivitis—Methotrexate—muscle cancer	0.000402	0.00147	CcSEcCtD
Boceprevir—Dysphagia—Doxorubicin—muscle cancer	0.000402	0.00146	CcSEcCtD
Boceprevir—Influenza—Doxorubicin—muscle cancer	0.000402	0.00146	CcSEcCtD
Boceprevir—Hypersensitivity—Vincristine—muscle cancer	0.0004	0.00146	CcSEcCtD
Boceprevir—Eosinophilia—Doxorubicin—muscle cancer	0.000398	0.00145	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—CD34—muscle cancer	0.000396	0.0133	CbGpPWpGaD
Boceprevir—Paraesthesia—Etoposide—muscle cancer	0.000395	0.00144	CcSEcCtD
Boceprevir—Pancreatitis—Doxorubicin—muscle cancer	0.000394	0.00144	CcSEcCtD
Boceprevir—Dyspnoea—Etoposide—muscle cancer	0.000393	0.00143	CcSEcCtD
Boceprevir—Hepatobiliary disease—Methotrexate—muscle cancer	0.000391	0.00143	CcSEcCtD
Boceprevir—Epistaxis—Methotrexate—muscle cancer	0.00039	0.00142	CcSEcCtD
Boceprevir—Asthenia—Vincristine—muscle cancer	0.00039	0.00142	CcSEcCtD
Boceprevir—Vomiting—Dactinomycin—muscle cancer	0.000387	0.00141	CcSEcCtD
Boceprevir—Bronchitis—Doxorubicin—muscle cancer	0.000386	0.00141	CcSEcCtD
Boceprevir—Agranulocytosis—Methotrexate—muscle cancer	0.000386	0.00141	CcSEcCtD
Boceprevir—Rash—Dactinomycin—muscle cancer	0.000384	0.0014	CcSEcCtD
Boceprevir—Decreased appetite—Etoposide—muscle cancer	0.000383	0.0014	CcSEcCtD
Boceprevir—Pancytopenia—Doxorubicin—muscle cancer	0.000381	0.00139	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Etoposide—muscle cancer	0.00038	0.00139	CcSEcCtD
Boceprevir—Fatigue—Etoposide—muscle cancer	0.00038	0.00138	CcSEcCtD
Boceprevir—CYP3A5—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000377	0.0126	CbGpPWpGaD
Boceprevir—Constipation—Etoposide—muscle cancer	0.000377	0.00137	CcSEcCtD
Boceprevir—Pain—Etoposide—muscle cancer	0.000377	0.00137	CcSEcCtD
Boceprevir—Neutropenia—Doxorubicin—muscle cancer	0.000376	0.00137	CcSEcCtD
Boceprevir—Dysuria—Doxorubicin—muscle cancer	0.000376	0.00137	CcSEcCtD
Boceprevir—Diarrhoea—Vincristine—muscle cancer	0.000372	0.00136	CcSEcCtD
Boceprevir—Pollakiuria—Doxorubicin—muscle cancer	0.000371	0.00135	CcSEcCtD
Boceprevir—Pharyngitis—Methotrexate—muscle cancer	0.000368	0.00134	CcSEcCtD
Boceprevir—Urinary tract disorder—Methotrexate—muscle cancer	0.000367	0.00134	CcSEcCtD
Boceprevir—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000367	0.00134	CcSEcCtD
Boceprevir—Urethral disorder—Methotrexate—muscle cancer	0.000364	0.00133	CcSEcCtD
Boceprevir—Weight decreased—Doxorubicin—muscle cancer	0.000363	0.00132	CcSEcCtD
Boceprevir—Feeling abnormal—Etoposide—muscle cancer	0.000363	0.00132	CcSEcCtD
Boceprevir—Hyperglycaemia—Doxorubicin—muscle cancer	0.000362	0.00132	CcSEcCtD
Boceprevir—Nausea—Dactinomycin—muscle cancer	0.000361	0.00132	CcSEcCtD
Boceprevir—Pneumonia—Doxorubicin—muscle cancer	0.00036	0.00131	CcSEcCtD
Boceprevir—Gastrointestinal pain—Etoposide—muscle cancer	0.00036	0.00131	CcSEcCtD
Boceprevir—Dizziness—Vincristine—muscle cancer	0.000359	0.00131	CcSEcCtD
Boceprevir—Infestation—Doxorubicin—muscle cancer	0.000358	0.00131	CcSEcCtD
Boceprevir—Infestation NOS—Doxorubicin—muscle cancer	0.000358	0.00131	CcSEcCtD
Boceprevir—Visual impairment—Methotrexate—muscle cancer	0.000358	0.0013	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000355	0.00129	CcSEcCtD
Boceprevir—Erythema multiforme—Methotrexate—muscle cancer	0.000351	0.00128	CcSEcCtD
Boceprevir—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000351	0.00128	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—KIDINS220—muscle cancer	0.00035	0.0117	CbGpPWpGaD
Boceprevir—Urticaria—Etoposide—muscle cancer	0.00035	0.00128	CcSEcCtD
Boceprevir—Stomatitis—Doxorubicin—muscle cancer	0.000349	0.00127	CcSEcCtD
Boceprevir—Abdominal pain—Etoposide—muscle cancer	0.000348	0.00127	CcSEcCtD
Boceprevir—Body temperature increased—Etoposide—muscle cancer	0.000348	0.00127	CcSEcCtD
Boceprevir—Urinary tract infection—Doxorubicin—muscle cancer	0.000348	0.00127	CcSEcCtD
Boceprevir—Conjunctivitis—Doxorubicin—muscle cancer	0.000348	0.00127	CcSEcCtD
Boceprevir—Eye disorder—Methotrexate—muscle cancer	0.000347	0.00126	CcSEcCtD
Boceprevir—Tinnitus—Methotrexate—muscle cancer	0.000346	0.00126	CcSEcCtD
Boceprevir—Vomiting—Vincristine—muscle cancer	0.000346	0.00126	CcSEcCtD
Boceprevir—Cardiac disorder—Methotrexate—muscle cancer	0.000345	0.00126	CcSEcCtD
Boceprevir—Rash—Vincristine—muscle cancer	0.000343	0.00125	CcSEcCtD
Boceprevir—Dermatitis—Vincristine—muscle cancer	0.000342	0.00125	CcSEcCtD
Boceprevir—Headache—Vincristine—muscle cancer	0.000341	0.00124	CcSEcCtD
Boceprevir—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000339	0.00123	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—FOXO4—muscle cancer	0.000339	0.0113	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—FOXO4—muscle cancer	0.000339	0.0113	CbGpPWpGaD
Boceprevir—Epistaxis—Doxorubicin—muscle cancer	0.000338	0.00123	CcSEcCtD
Boceprevir—Angiopathy—Methotrexate—muscle cancer	0.000337	0.00123	CcSEcCtD
Boceprevir—Sinusitis—Doxorubicin—muscle cancer	0.000336	0.00122	CcSEcCtD
Boceprevir—Immune system disorder—Methotrexate—muscle cancer	0.000335	0.00122	CcSEcCtD
Boceprevir—Mediastinal disorder—Methotrexate—muscle cancer	0.000335	0.00122	CcSEcCtD
Boceprevir—Agranulocytosis—Doxorubicin—muscle cancer	0.000334	0.00122	CcSEcCtD
Boceprevir—Chills—Methotrexate—muscle cancer	0.000333	0.00121	CcSEcCtD
Boceprevir—Alopecia—Methotrexate—muscle cancer	0.000328	0.0012	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—CD34—muscle cancer	0.000326	0.0109	CbGpPWpGaD
Boceprevir—Mental disorder—Methotrexate—muscle cancer	0.000325	0.00119	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—FOXO4—muscle cancer	0.000325	0.0109	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—FOXO4—muscle cancer	0.000325	0.0109	CbGpPWpGaD
Boceprevir—Hypersensitivity—Etoposide—muscle cancer	0.000324	0.00118	CcSEcCtD
Boceprevir—Malnutrition—Methotrexate—muscle cancer	0.000323	0.00118	CcSEcCtD
Boceprevir—Erythema—Methotrexate—muscle cancer	0.000323	0.00118	CcSEcCtD
Boceprevir—Nausea—Vincristine—muscle cancer	0.000323	0.00118	CcSEcCtD
Boceprevir—Rhinitis—Doxorubicin—muscle cancer	0.000322	0.00117	CcSEcCtD
Boceprevir—Hypoaesthesia—Doxorubicin—muscle cancer	0.00032	0.00117	CcSEcCtD
Boceprevir—Pharyngitis—Doxorubicin—muscle cancer	0.000319	0.00116	CcSEcCtD
Boceprevir—Urinary tract disorder—Doxorubicin—muscle cancer	0.000317	0.00116	CcSEcCtD
Boceprevir—Oedema peripheral—Doxorubicin—muscle cancer	0.000317	0.00115	CcSEcCtD
Boceprevir—Dysgeusia—Methotrexate—muscle cancer	0.000316	0.00115	CcSEcCtD
Boceprevir—Asthenia—Etoposide—muscle cancer	0.000316	0.00115	CcSEcCtD
Boceprevir—Connective tissue disorder—Doxorubicin—muscle cancer	0.000316	0.00115	CcSEcCtD
Boceprevir—Urethral disorder—Doxorubicin—muscle cancer	0.000315	0.00115	CcSEcCtD
Boceprevir—Back pain—Methotrexate—muscle cancer	0.000313	0.00114	CcSEcCtD
Boceprevir—Pruritus—Etoposide—muscle cancer	0.000312	0.00114	CcSEcCtD
Boceprevir—Visual impairment—Doxorubicin—muscle cancer	0.00031	0.00113	CcSEcCtD
Boceprevir—Vision blurred—Methotrexate—muscle cancer	0.000305	0.00111	CcSEcCtD
Boceprevir—Erythema multiforme—Doxorubicin—muscle cancer	0.000304	0.00111	CcSEcCtD
Boceprevir—Diarrhoea—Etoposide—muscle cancer	0.000301	0.0011	CcSEcCtD
Boceprevir—Eye disorder—Doxorubicin—muscle cancer	0.0003	0.00109	CcSEcCtD
Boceprevir—Ill-defined disorder—Methotrexate—muscle cancer	0.0003	0.00109	CcSEcCtD
Boceprevir—Tinnitus—Doxorubicin—muscle cancer	0.0003	0.00109	CcSEcCtD
Boceprevir—Anaemia—Methotrexate—muscle cancer	0.000299	0.00109	CcSEcCtD
Boceprevir—Flushing—Doxorubicin—muscle cancer	0.000298	0.00109	CcSEcCtD
Boceprevir—Cardiac disorder—Doxorubicin—muscle cancer	0.000298	0.00109	CcSEcCtD
Boceprevir—Angiopathy—Doxorubicin—muscle cancer	0.000292	0.00106	CcSEcCtD
Boceprevir—Malaise—Methotrexate—muscle cancer	0.000291	0.00106	CcSEcCtD
Boceprevir—Dizziness—Etoposide—muscle cancer	0.000291	0.00106	CcSEcCtD
Boceprevir—Immune system disorder—Doxorubicin—muscle cancer	0.00029	0.00106	CcSEcCtD
Boceprevir—Vertigo—Methotrexate—muscle cancer	0.00029	0.00106	CcSEcCtD
Boceprevir—CTSL—Immune System—CD34—muscle cancer	0.00029	0.00971	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD34—muscle cancer	0.00029	0.00971	CbGpPWpGaD
Boceprevir—Mediastinal disorder—Doxorubicin—muscle cancer	0.00029	0.00106	CcSEcCtD
Boceprevir—Leukopenia—Methotrexate—muscle cancer	0.000289	0.00105	CcSEcCtD
Boceprevir—Chills—Doxorubicin—muscle cancer	0.000288	0.00105	CcSEcCtD
Boceprevir—Arrhythmia—Doxorubicin—muscle cancer	0.000287	0.00105	CcSEcCtD
Boceprevir—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000284	0.00951	CbGpPWpGaD
Boceprevir—Alopecia—Doxorubicin—muscle cancer	0.000284	0.00104	CcSEcCtD
Boceprevir—Cough—Methotrexate—muscle cancer	0.000282	0.00103	CcSEcCtD
Boceprevir—Mental disorder—Doxorubicin—muscle cancer	0.000282	0.00103	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—FOXO4—muscle cancer	0.000281	0.00939	CbGpPWpGaD
Boceprevir—Vomiting—Etoposide—muscle cancer	0.00028	0.00102	CcSEcCtD
Boceprevir—Erythema—Doxorubicin—muscle cancer	0.00028	0.00102	CcSEcCtD
Boceprevir—Malnutrition—Doxorubicin—muscle cancer	0.00028	0.00102	CcSEcCtD
Boceprevir—Rash—Etoposide—muscle cancer	0.000278	0.00101	CcSEcCtD
Boceprevir—Dermatitis—Etoposide—muscle cancer	0.000277	0.00101	CcSEcCtD
Boceprevir—Headache—Etoposide—muscle cancer	0.000276	0.00101	CcSEcCtD
Boceprevir—Flatulence—Doxorubicin—muscle cancer	0.000276	0.00101	CcSEcCtD
Boceprevir—Arthralgia—Methotrexate—muscle cancer	0.000275	0.001	CcSEcCtD
Boceprevir—Myalgia—Methotrexate—muscle cancer	0.000275	0.001	CcSEcCtD
Boceprevir—Chest pain—Methotrexate—muscle cancer	0.000275	0.001	CcSEcCtD
Boceprevir—Dysgeusia—Doxorubicin—muscle cancer	0.000274	0.000999	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000273	0.000996	CcSEcCtD
Boceprevir—Discomfort—Methotrexate—muscle cancer	0.000272	0.000991	CcSEcCtD
Boceprevir—Back pain—Doxorubicin—muscle cancer	0.000271	0.000987	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—FOXO4—muscle cancer	0.000269	0.00901	CbGpPWpGaD
Boceprevir—Muscle spasms—Doxorubicin—muscle cancer	0.000269	0.000981	CcSEcCtD
Boceprevir—Confusional state—Methotrexate—muscle cancer	0.000266	0.000969	CcSEcCtD
Boceprevir—Vision blurred—Doxorubicin—muscle cancer	0.000264	0.000961	CcSEcCtD
Boceprevir—Infection—Methotrexate—muscle cancer	0.000262	0.000955	CcSEcCtD
Boceprevir—Nausea—Etoposide—muscle cancer	0.000262	0.000953	CcSEcCtD
Boceprevir—Ill-defined disorder—Doxorubicin—muscle cancer	0.00026	0.000946	CcSEcCtD
Boceprevir—Nervous system disorder—Methotrexate—muscle cancer	0.000259	0.000943	CcSEcCtD
Boceprevir—Anaemia—Doxorubicin—muscle cancer	0.000259	0.000943	CcSEcCtD
Boceprevir—Thrombocytopenia—Methotrexate—muscle cancer	0.000258	0.000941	CcSEcCtD
Boceprevir—Agitation—Doxorubicin—muscle cancer	0.000257	0.000937	CcSEcCtD
Boceprevir—Skin disorder—Methotrexate—muscle cancer	0.000256	0.000934	CcSEcCtD
Boceprevir—Hyperhidrosis—Methotrexate—muscle cancer	0.000255	0.000929	CcSEcCtD
Boceprevir—Malaise—Doxorubicin—muscle cancer	0.000252	0.00092	CcSEcCtD
Boceprevir—Vertigo—Doxorubicin—muscle cancer	0.000251	0.000916	CcSEcCtD
Boceprevir—Syncope—Doxorubicin—muscle cancer	0.000251	0.000915	CcSEcCtD
Boceprevir—Leukopenia—Doxorubicin—muscle cancer	0.00025	0.000913	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—FOXO1—muscle cancer	0.00025	0.00837	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—FOXO1—muscle cancer	0.00025	0.00837	CbGpPWpGaD
Boceprevir—Palpitations—Doxorubicin—muscle cancer	0.000247	0.000901	CcSEcCtD
Boceprevir—Hypotension—Methotrexate—muscle cancer	0.000246	0.000898	CcSEcCtD
Boceprevir—Loss of consciousness—Doxorubicin—muscle cancer	0.000246	0.000896	CcSEcCtD
Boceprevir—Cough—Doxorubicin—muscle cancer	0.000244	0.00089	CcSEcCtD
Boceprevir—Hypertension—Doxorubicin—muscle cancer	0.000242	0.000881	CcSEcCtD
Boceprevir—CTSK—Immune System—CD34—muscle cancer	0.00024	0.00804	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00024	0.000876	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—FOXO1—muscle cancer	0.00024	0.00803	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—FOXO1—muscle cancer	0.00024	0.00803	CbGpPWpGaD
Boceprevir—Insomnia—Methotrexate—muscle cancer	0.000239	0.000869	CcSEcCtD
Boceprevir—Chest pain—Doxorubicin—muscle cancer	0.000238	0.000868	CcSEcCtD
Boceprevir—Arthralgia—Doxorubicin—muscle cancer	0.000238	0.000868	CcSEcCtD
Boceprevir—Myalgia—Doxorubicin—muscle cancer	0.000238	0.000868	CcSEcCtD
Boceprevir—Anxiety—Doxorubicin—muscle cancer	0.000237	0.000865	CcSEcCtD
Boceprevir—Paraesthesia—Methotrexate—muscle cancer	0.000237	0.000863	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000237	0.000862	CcSEcCtD
Boceprevir—Discomfort—Doxorubicin—muscle cancer	0.000235	0.000858	CcSEcCtD
Boceprevir—Dyspnoea—Methotrexate—muscle cancer	0.000235	0.000857	CcSEcCtD
Boceprevir—Dry mouth—Doxorubicin—muscle cancer	0.000233	0.000849	CcSEcCtD
Boceprevir—Dyspepsia—Methotrexate—muscle cancer	0.000232	0.000846	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—FOXO4—muscle cancer	0.000231	0.00773	CbGpPWpGaD
Boceprevir—Confusional state—Doxorubicin—muscle cancer	0.00023	0.000839	CcSEcCtD
Boceprevir—Decreased appetite—Methotrexate—muscle cancer	0.000229	0.000836	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000228	0.00083	CcSEcCtD
Boceprevir—Fatigue—Methotrexate—muscle cancer	0.000227	0.000829	CcSEcCtD
Boceprevir—Infection—Doxorubicin—muscle cancer	0.000227	0.000827	CcSEcCtD
Boceprevir—Pain—Methotrexate—muscle cancer	0.000226	0.000822	CcSEcCtD
Boceprevir—Shock—Doxorubicin—muscle cancer	0.000225	0.000819	CcSEcCtD
Boceprevir—Nervous system disorder—Doxorubicin—muscle cancer	0.000224	0.000816	CcSEcCtD
Boceprevir—Thrombocytopenia—Doxorubicin—muscle cancer	0.000224	0.000815	CcSEcCtD
Boceprevir—Tachycardia—Doxorubicin—muscle cancer	0.000223	0.000812	CcSEcCtD
Boceprevir—Skin disorder—Doxorubicin—muscle cancer	0.000222	0.000809	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—FOXO4—muscle cancer	0.000222	0.00742	CbGpPWpGaD
Boceprevir—Hyperhidrosis—Doxorubicin—muscle cancer	0.000221	0.000805	CcSEcCtD
Boceprevir—CMA1—Metabolism of proteins—IGF2—muscle cancer	0.000221	0.00738	CbGpPWpGaD
Boceprevir—Feeling abnormal—Methotrexate—muscle cancer	0.000217	0.000792	CcSEcCtD
Boceprevir—Gastrointestinal pain—Methotrexate—muscle cancer	0.000216	0.000786	CcSEcCtD
Boceprevir—Hypotension—Doxorubicin—muscle cancer	0.000213	0.000778	CcSEcCtD
Boceprevir—Urticaria—Methotrexate—muscle cancer	0.00021	0.000764	CcSEcCtD
Boceprevir—Abdominal pain—Methotrexate—muscle cancer	0.000209	0.00076	CcSEcCtD
Boceprevir—Body temperature increased—Methotrexate—muscle cancer	0.000209	0.00076	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000208	0.000758	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—FOXO1—muscle cancer	0.000207	0.00693	CbGpPWpGaD
Boceprevir—Insomnia—Doxorubicin—muscle cancer	0.000207	0.000753	CcSEcCtD
Boceprevir—Paraesthesia—Doxorubicin—muscle cancer	0.000205	0.000747	CcSEcCtD
Boceprevir—Dyspnoea—Doxorubicin—muscle cancer	0.000204	0.000742	CcSEcCtD
Boceprevir—Dyspepsia—Doxorubicin—muscle cancer	0.000201	0.000733	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—FOXO1—muscle cancer	0.000199	0.00666	CbGpPWpGaD
Boceprevir—Decreased appetite—Doxorubicin—muscle cancer	0.000199	0.000724	CcSEcCtD
Boceprevir—CTSS—Immune System—CD34—muscle cancer	0.000198	0.00662	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FOXO4—muscle cancer	0.000197	0.0066	CbGpPWpGaD
Boceprevir—CTSV—Immune System—FOXO4—muscle cancer	0.000197	0.0066	CbGpPWpGaD
Boceprevir—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000197	0.000719	CcSEcCtD
Boceprevir—Fatigue—Doxorubicin—muscle cancer	0.000197	0.000718	CcSEcCtD
Boceprevir—Constipation—Doxorubicin—muscle cancer	0.000195	0.000712	CcSEcCtD
Boceprevir—Pain—Doxorubicin—muscle cancer	0.000195	0.000712	CcSEcCtD
Boceprevir—Hypersensitivity—Methotrexate—muscle cancer	0.000194	0.000708	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—KIT—muscle cancer	0.000191	0.00637	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—KIT—muscle cancer	0.000191	0.00637	CbGpPWpGaD
Boceprevir—Asthenia—Methotrexate—muscle cancer	0.000189	0.00069	CcSEcCtD
Boceprevir—Feeling abnormal—Doxorubicin—muscle cancer	0.000188	0.000686	CcSEcCtD
Boceprevir—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000187	0.000681	CcSEcCtD
Boceprevir—Pruritus—Methotrexate—muscle cancer	0.000187	0.00068	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—KIT—muscle cancer	0.000183	0.00612	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—KIT—muscle cancer	0.000183	0.00612	CbGpPWpGaD
Boceprevir—Urticaria—Doxorubicin—muscle cancer	0.000181	0.000661	CcSEcCtD
Boceprevir—Abdominal pain—Doxorubicin—muscle cancer	0.000181	0.000658	CcSEcCtD
Boceprevir—Body temperature increased—Doxorubicin—muscle cancer	0.000181	0.000658	CcSEcCtD
Boceprevir—Diarrhoea—Methotrexate—muscle cancer	0.00018	0.000658	CcSEcCtD
Boceprevir—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000175	0.00586	CbGpPWpGaD
Boceprevir—Dizziness—Methotrexate—muscle cancer	0.000174	0.000636	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—FOXO1—muscle cancer	0.000171	0.00571	CbGpPWpGaD
Boceprevir—Hypersensitivity—Doxorubicin—muscle cancer	0.000168	0.000613	CcSEcCtD
Boceprevir—Vomiting—Methotrexate—muscle cancer	0.000168	0.000611	CcSEcCtD
Boceprevir—Rash—Methotrexate—muscle cancer	0.000166	0.000606	CcSEcCtD
Boceprevir—Dermatitis—Methotrexate—muscle cancer	0.000166	0.000606	CcSEcCtD
Boceprevir—Headache—Methotrexate—muscle cancer	0.000165	0.000602	CcSEcCtD
Boceprevir—Asthenia—Doxorubicin—muscle cancer	0.000164	0.000597	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—FOXO1—muscle cancer	0.000164	0.00548	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FOXO4—muscle cancer	0.000163	0.00547	CbGpPWpGaD
Boceprevir—Pruritus—Doxorubicin—muscle cancer	0.000162	0.000589	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—KIT—muscle cancer	0.000158	0.00528	CbGpPWpGaD
Boceprevir—Nausea—Methotrexate—muscle cancer	0.000157	0.000571	CcSEcCtD
Boceprevir—Diarrhoea—Doxorubicin—muscle cancer	0.000156	0.00057	CcSEcCtD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	0.000154	0.00516	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—KIT—muscle cancer	0.000152	0.00507	CbGpPWpGaD
Boceprevir—Dizziness—Doxorubicin—muscle cancer	0.000151	0.00055	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—MDM2—muscle cancer	0.00015	0.00502	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—MDM2—muscle cancer	0.00015	0.00502	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FOXO1—muscle cancer	0.000146	0.00487	CbGpPWpGaD
Boceprevir—CTSV—Immune System—FOXO1—muscle cancer	0.000146	0.00487	CbGpPWpGaD
Boceprevir—Vomiting—Doxorubicin—muscle cancer	0.000145	0.000529	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—MDM2—muscle cancer	0.000144	0.00482	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—MDM2—muscle cancer	0.000144	0.00482	CbGpPWpGaD
Boceprevir—Rash—Doxorubicin—muscle cancer	0.000144	0.000525	CcSEcCtD
Boceprevir—Dermatitis—Doxorubicin—muscle cancer	0.000144	0.000524	CcSEcCtD
Boceprevir—Headache—Doxorubicin—muscle cancer	0.000143	0.000521	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—PTCH1—muscle cancer	0.000138	0.00461	CbGpPWpGaD
Boceprevir—Nausea—Doxorubicin—muscle cancer	0.000136	0.000494	CcSEcCtD
Boceprevir—CTSS—Immune System—FOXO4—muscle cancer	0.000135	0.0045	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—KIT—muscle cancer	0.00013	0.00435	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000126	0.00422	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—KIT—muscle cancer	0.000125	0.00418	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—MDM2—muscle cancer	0.000124	0.00416	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FOXO1—muscle cancer	0.000121	0.00404	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—MDM2—muscle cancer	0.000119	0.00399	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FOXO4—muscle cancer	0.000119	0.00397	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CNR1—muscle cancer	0.000116	0.00389	CbGpPWpGaD
Boceprevir—CTSV—Immune System—KIT—muscle cancer	0.000111	0.00371	CbGpPWpGaD
Boceprevir—CTSL—Immune System—KIT—muscle cancer	0.000111	0.00371	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—MDM2—muscle cancer	0.000102	0.00343	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FOXO1—muscle cancer	9.94e-05	0.00332	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—MDM2—muscle cancer	9.83e-05	0.00329	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IGF2—muscle cancer	9.51e-05	0.00318	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	9.22e-05	0.00309	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KIT—muscle cancer	9.19e-05	0.00308	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FOXO1—muscle cancer	8.75e-05	0.00293	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MDM2—muscle cancer	8.74e-05	0.00292	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MDM2—muscle cancer	8.74e-05	0.00292	CbGpPWpGaD
Boceprevir—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	7.86e-05	0.00263	CbGpPWpGaD
Boceprevir—CTSS—Immune System—KIT—muscle cancer	7.57e-05	0.00253	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	7.26e-05	0.00243	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MDM2—muscle cancer	7.24e-05	0.00242	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KIT—muscle cancer	6.67e-05	0.00223	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—muscle cancer	6.29e-05	0.0021	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MDM2—muscle cancer	5.96e-05	0.002	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—FH—muscle cancer	5.41e-05	0.00181	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MDM2—muscle cancer	5.25e-05	0.00176	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	4.09e-05	0.00137	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—FH—muscle cancer	4.08e-05	0.00137	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—muscle cancer	3.99e-05	0.00133	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	3.94e-05	0.00132	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	3.1e-05	0.00104	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MED12—muscle cancer	3.06e-05	0.00102	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—muscle cancer	3.01e-05	0.00101	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ENO2—muscle cancer	2.79e-05	0.000933	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—FH—muscle cancer	2.52e-05	0.000842	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	2.34e-05	0.000785	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MED12—muscle cancer	2.31e-05	0.000772	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ENO2—muscle cancer	2.1e-05	0.000704	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MED12—muscle cancer	1.42e-05	0.000476	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ENO2—muscle cancer	1.3e-05	0.000434	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—muscle cancer	9.71e-06	0.000325	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—muscle cancer	7.33e-06	0.000245	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—muscle cancer	4.51e-06	0.000151	CbGpPWpGaD
